12-24 Hours
ব্যবসার জন্য পাইকারি দামে পণ্য কিনতে রেজিস্টেশন করুন
Register
Safety Advices
বাংলা
English
UNSAFE
It is unsafe to consume alcohol with Litiam ER.
CONSULT YOUR DOCTOR
Litiam ER is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
SAFE IF PRESCRIBED
Litiam ER is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
UNSAFE
Litiam ER may cause side effects which could affect your ability to drive.
Litiam ER may make you feel sleepy, tired or dizzy. Litiam ER may also cause other effects that can make it dangerous to drive such as numbness, paralysis, weakness or fits (seizures).
CAUTION
Litiam ER should be used with caution in patients with kidney disease. Dose adjustment of Litiam ER may be needed. Please consult your doctor.
Use of Litiam ER is not recommended in patients with severe kidney disease.
SAFE IF PRESCRIBED
Litiam ER is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Litiam ER may not be needed in these patients. Please consult your doctor.
Medicine Overview of Litiam ER 400mg Tablet
Introduction
Litiam ER is a prescription medicine used in the treatment of bipolar disorder and mania in adults. It is sometimes used to treat other behavioral disorders as well. It reduces the frequency of manic episodes and decreases the intensity of those episodes that might occur. Litiam ER should be taken with food. However, it is advised to take it at the same time each day as this helps to maintain a consistent level of medicine in the body. Do not skip any doses and finish the full course of treatment even if you feel better. If you have missed a...
... Show moreUses of Litiam ER
- Mania
- Bipolar disoder
Side effects of Litiam ER
Common
- Tremor
- Slurred speech
- Uncoordinated body movements
- Nausea
- Acne
- Increased white blood cell count
- Memory impairment
- Hair loss
- Goiter (enlarged thyroid gland)
- Skin rash
- Increased thirst
- Weight gain
- Polyuria
- Diarrhea
How to use Litiam ER
Use it as advised by your doctor or check the label for directions before use. Litiam ER is to be taken with food.
How Litiam ER works
Litiam ER works by suppressing the abnormal and excessive activity of the nerve cells in the brain.
Quick Tips
- Lithosun SR Tablet is one of the most effective long-term treatment for bipolar disorder.
- It may also be used for the treatment of mania.
- Your lithium blood levels, thyroid function, and kidney function may be monitored as long as you take this medicine.
- It may cause diarrhea and dehydration. Drink plenty of water and and use normal amounts of salt. Inform your doctor if you start or stop a low-salt diet.
- Monitor your weight during treatment as Lithosun SR Tablet can cause weight gain.
- Do not drive or do anything that requires mental focus until you know how it affects you.
- Inform your doctor if you have persistent stomach upset, problems with your speech, or extreme drowsiness. Your dose may need to be adjusted.
- Do not take Lithosun SR Tablet if you are pregnant or breastfeeding.
- Do not stop taking the medication suddenly without talking to your doctor.
Brief Description
Indication
Bipolar disorder, Mania, Recurrent unipolar depression
Administration
Should be taken with food.
Adult Dose
Oral
Mania; Bipolar disorder; Recurrent unipolar depression
Adult: Treatment and prevention: Initially, 400-1,200 mg daily in 1-2 divided doses.
Serum lithium should be monitored 12 hours after dose, twice weekly until serum concentration and clinical condition stabilize, and every other month thereafter
Desirable range for serum lithium: 0.6-1.2 mEq/L; although higher serum concentrations may be needed, not to exceed 1.5 mEq/L
Renal Dose
Renal impairment:
CrCl (ml/min) Dosage Recommendation
10-50 50-75% of normal dose.
<10 25-50% of normal dose.
Contraindication
Renal insufficiency, cardiovascular insufficiency, Addison\'s disease and untreated hypothyroidism are all contraindications to lithium therapy.
Mode of Action
Inhibits postsynaptic D2 receptor supersensitivity. Alters cation transport in nerve and muscle cells and influences reuptake of serotonin or norepinephrine. Inhibits phosphatidylinositol cycle second messenger systems.
Precaution
Decreased tolerance to lithium has been reported to ensue from protracted sweating or diarrhoea and, if such occur, supplemental fluid and salt should be administered under careful medical supervision and lithium intake reduced or suspended until the condition is resolved.
Lactation: Drug is excreted in breast milk; use not recommended
Side Effect
>10%
Leukocytosis (most patients),Polyuria/polydypsia (30-50%),Dry mouth (20-50%),Hand tremor (45% initially, 10% after 1 year of treatment),Confusion (40%),Decreased memory (40%),Headache (40%),Muscle weakness (30% initially, 1% after 1 year of treatment),Electrocardiographic (ECG) changes (20-30%),Nausea, vomiting, diarrhea (10-30% initially, 1-10% after 1-2 years of treatment),Hyperreflexia (15%),Muscle twitch (15%),Vertigo (15%)
1-10%
Extrapyramidal symptoms, goiter (5%),Hypothyroidism (1-4%),Acne (1%),Hair thinning (1%)
Frequency Not Defined
Coma,Lethargy,Seizures,Renal toxicity
Interaction
Reduced serum levels with carbonic anhydrase inhibitors, chlorpromazine, sodium-containing preparations, theophylline, urea. Enhanced hypothyroid effects with iodine salts. Enhanced effects of neuromuscular-blocking agents. Reduced pressor response to sympathomimetics.
Potentially Fatal: Increased risk of lithium toxicity with ACE inhibitors, angiotensin receptor antagonists, loop diuretics, metronidazole, phenytoin. Increased risk of neurotoxicity with carbamazepine, calcium-channel blockers, haloperidol, methyldopa, phenothiazines, SSRIs, TCAs. Increased serum levels with COX-2 inhibitors, NSAIDs (except sulindac, aspirin), tetracyclines, thiazide diuretics. Increased risk of encephalopathy with haloperidol. Increased risk of serotonin syndrome with sibutramine. Fatal malignant hyperpyrexia may occur when used with MAOIs.
ব্যবসার জন্য পাইকারি দামে পণ্য কিনতে রেজিস্টেশন করুন
Register
